15 results
8-K
EX-99.1
MIRO
Miromatrix Medical Inc.
14 Aug 23
Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update
4:01pm
in National Kidney Foundation's ("NKF") Innovation Day congressional event
Participated in Association of Organ Procurement Organizations ("AOPO
8-K
EX-99.1
MIRO
Miromatrix Medical Inc.
11 May 23
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update
4:01pm
"The Pioneer Tax: Challenges and Opportunities of Being at the Forefront of Innovation"
Upcoming presentations at the American Transplant Congress
10-K
2021 FY
MIRO
Miromatrix Medical Inc.
30 Mar 22
Annual report
4:34pm
Price Competition and Innovation Act of 2009. That Act created an approval pathway authorizing the FDA to approve biosimilars and interchangeable … .
Even if we are able to successfully develop biologics in the future, the Biologics Price Competition and Innovation Act created a framework
8-K
EX-99.1
md7gybl7eni hbihnte
14 Oct 21
Successful transplant of bioengineered organs in large animals is a critical milestone on the road to in-human transplants
7:48am
424B4
fude4eockez0v4
24 Jun 21
Prospectus supplement with pricing info
4:26pm
S-1/A
wogoh yzdm7elyd
10 Jun 21
IPO registration (amended)
9:05am
S-1
6dtqqwuht jb2v9x
28 May 21
IPO registration
5:02pm
DRS/A
EX-10.17
f4avolxm1 fao
6 May 21
Draft registration statement (amended)
12:00am
DRS/A
09lpryaah0fph5utd5
6 May 21
Draft registration statement (amended)
12:00am
DRS
v2hmsz6gx8ezk 4315j
29 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next